Inventor · Copenhagen, DK

Ditte Riber

31Patents

12h-index

27Co-inventors

77Inventor score

Filing activity: Jun 16, 2008 → Jul 7, 2021

Most-cited inventions

Patent	Title	Area	Cited by	Status
US7994122B2	Glucagon analogues	Human Necessities	55	Active
US9180169B2	Glucagon analogues	Human Necessities	26	Active
US8642541B2	Glucagon analogues	Human Necessities	26	Active
US8642540B2	Glucagon analogues	Human Necessities	25	Active
US8680049B2	Glucagon analogues	Human Necessities	25	Active
US8685919B2	Glucagon analogues	Human Necessities	25	Active
US9156901B2	Acylated glucagon analogues	Chemistry; Metallurgy	24	Active
US9896495B2	Acylated glucagon analogues	Emerging Cross-Sectional Technologies	24	Active
US9169310B2	Glucagon analogues	Human Necessities	22	Active
US9403894B2	Glucagon analogues	Human Necessities	21	Active
US9453064B2	Glucagon-like-peptide-2 (GLP-2) analogues	Human Necessities	16	Active
US9969787B2	Glucagon-like-peptide-2 (GLP-2) analogues	Human Necessities	12	Active
US10100097B2	GIP-GLP-1 dual agonist compounds and methods	Chemistry; Metallurgy	12	Active
US9975939B2	Glucagon analogues	Human Necessities	11	Active
US9988429B2	Glucagon analogues	Human Necessities	11	Active
US10004786B2	Acylated glucagon analogues	Chemistry; Metallurgy	11	Active
US10131702B2	Glucagon-GLP-1-GIP triple agonist compounds	Human Necessities	6	Active
US9657062B2	Ghrelin analogues	Human Necessities	2	Active
US10253080B2	Glucagon-like-peptide-2 (GLP-2) analogues	Human Necessities	1	Active
US10457714B2	Acylated glucagon analogues	Emerging Cross-Sectional Technologies	1	Active
US10442847B2	Glucagon analogues	Human Necessities	1	Active
US11274136B2	Acylated glucagon analogue	Human Necessities	0	Active
US11034747B2	Glucagon analogues and methods of use	Human Necessities	0	Active
US12297250B2	Modified GIP peptide analogues	Human Necessities	0	Active
US11884713B2	Acylated glucagon analogues	Emerging Cross-Sectional Technologies	0	Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.